COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1305: Articles 13041-13050  | Next

The SARS-CoV-2 Alpha variant is associated with increased clinical severity of disease
Pascall, D. J., Mollett, G., Blacow, R., Bulteel, N., Campbell, R., Campbell, A., Clifford, S., Davis, C., da Silva Filipe, A., Fjodorova, L., Forrest, R., Goldstein, E., Gunson, R., Haughney, J., Holden, M. T., Honour, P., Hughes, J., James, E., Lewis, T., Lycett, S. J., McHugh, M., Onishi, Y., Parcell, B., Robertson, D. L., El Sakka, N., Shabaan, S., Shepherd, J. G., Smollett, K., Templeton, K., Vink, E., Westnedge, E., Williams, T., The COVID-19 Genomics UK (COG-UK) consortium, , Thomson, E. C.
10.1101/2021.08.17.21260128 — Posted: 2021-08-24
Men are the main COVID-19 transmitters: lessons from couples
Silva, M. V. R., de Castro, M. V., Passos-Bueno, M. R., Otto, P. A., Naslavsky, M. S., Zatz, M.
10.1101/2021.08.18.21262187 — Posted: 2021-08-24
Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland.
McKeigue, P. M., Burgul, R., Bishop, J., Robertson, C., McMenamin, J., O'Leary, M., McAllister, D. A., Colhoun, H. M.
10.1101/2021.08.23.21261779 — Posted: 2021-08-24
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Pouwels, K. B., Pritchard, E., Matthews, P., Stoesser, N. B., Eyre, D. W., Vihta, K.-D., House, T., Hay, J., Bell, J., Newton, J., Farrar, J., Crook, D. W., Cook, D., Rourke, E., Studley, R., Peto, T. E., Diamond, I., Walker, S., COVID-19 Infection Survey Team
10.1101/2021.08.18.21262237 — Posted: 2021-08-24 Discussion: Onsite
Assessing the impact of adherence to Non-pharmaceutical interventions and indirect transmission on the dynamics of COVID-19: a mathematical modelling study
Iyaniwura, S. A., Rabiu, M. A., David, J., Kong, J. D.
10.1101/2021.08.16.21262135 — Posted: 2021-08-24
Urban Tertiary Care Centre Experience of Characteristics of Severe COVID-19 Pneumonia
Shah, N. M., Khambholja, J. R., Suthar, N. N., Tiwari, H., Desai, V., Beriwala, V.
10.1101/2021.08.16.21262073 — Posted: 2021-08-24
The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection
Scheepers, C., Everatt, J., Amoako, D. G., Mnguni, A., Ismail, A., Mahlangu, B., Wibmer, C. K., Wilkinson, E., Tegally, H., San, J. E., Giandhari, J., Ntuli, N., Pillay, S., Mohale, T., Naidoo, Y., Khumalo, Z., Makatini, Z., Network for Genomic Surveillance South Africa (NGS-SA), , Sigal, A., Williamson, C., Treurnicht, F., Mlisana, K., Venter, M., Hsiao, N.-y., Wolter, N., Msomi, N., Lessells, R., Maponga, T., Preiser, W., Moore, P. L., von Gottberg, A., De Oliveira, T., Bhiman, J.
10.1101/2021.08.20.21262342 — Posted: 2021-08-24 Discussion: Onsite
Inexpensive workflow for simultaneous monitoring of HIV viral load and detection of SARS-CoV-2 infection
Gulati, G. K., Panpradist, N., Stewart, S. W. A., Beck, I. A., Boyce, C., Oreskovic, A., Garcia-Morales, C., Avila-Rios, S., Han, P. D., Reyes-Teran, G., Starita, L. M., Frenkel, L. M., Lutz, B. R., Lai, J. J.
10.1101/2021.08.18.21256786 — Posted: 2021-08-24
Modelling the cost-effectiveness of essential and advanced critical care for COVID-19 patients in Kenya
Kairu, A., Were, V., Isaaka, L., Agweyu, A., Aketch, S., Barasa, E.
10.1101/2021.08.16.21261894 — Posted: 2021-08-24
Fall 2021 Resurgence and COVID-19 Seroprevalence in Canada: Modelling waning and boosting COVID-19 immunity in Canada, A Canadian Immunization Research Network Study
Dick, D. W., Childs, L. M., Feng, Z., Li, J., Rost, G., Buckeridge, D., Ogden, N., Heffernan, J. M.
10.1101/2021.08.17.21262188 — Posted: 2021-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).